BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15099952)

  • 1. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers.
    Sakaguchi H; Fujimoto J; Hong BL; Nakagawa Y; Tamaya T
    Gynecol Oncol; 2004 May; 93(2):394-9. PubMed ID: 15099952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
    Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
    Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
    O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
    Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma.
    Miyamoto T; Watanabe J; Hata H; Jobo T; Kawaguchi M; Hattori M; Saito M; Kuramoto H
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):111-8. PubMed ID: 15555905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression.
    Jazaeri AA; Nunes KJ; Dalton MS; Xu M; Shupnik MA; Rice LW
    Oncogene; 2001 Oct; 20(47):6965-9. PubMed ID: 11687977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of estrogen and progesterone receptor subtypes in human endometrial carcinoma tissues].
    Liao QP; Wu C; Zheng H; Yu L
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):752-5. PubMed ID: 16324249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of estrogen receptor-related receptor isoforms in endometrial carcinoma tissues and its clinical significance].
    Gao M; Wei LH; Sun PM; Zhao D; Wang JL; Wang ZQ; Zhao C
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):756-60. PubMed ID: 16324250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
    Fujimoto J; Hori M; Ichigo S; Tamaya T
    Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
    Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
    Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.
    Pijnenborg JM; Romano A; Dam-de Veen GC; Dunselman GA; Fischer DC; Groothuis PG; Kieback DG
    J Pathol; 2005 Apr; 205(5):597-605. PubMed ID: 15726651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant progesterone receptor mRNAs are co-expressed with the wild-type progesterone receptor mRNA in human endometrium during all phases of the menstrual cycle.
    Marshburn PB; Zhang J; Bahrani-Mostafavi Z; Matthews ML; White J; Hurst BS
    Mol Hum Reprod; 2005 Nov; 11(11):809-15. PubMed ID: 16339776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and regulation of progesterone receptor isoforms in rat and mouse pituitary cells and LbetaT2 gonadotropes.
    Turgeon JL; Waring DW
    J Endocrinol; 2006 Sep; 190(3):837-46. PubMed ID: 17003284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
    Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
    Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.